A novel vicious cycle cascade in tumor chemotherapy

Medical Hypotheses

Volumn 69, Issue 6, 2007, Pages 1230-1233

  Zhou, Hao ^a   Zou, Ping ^a   Chen, Zhi chao ^a   You, Yong ^a  

^a UNION HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; B7 ANTIGEN; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOWN REGULATION; HUMAN; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANTIGEN PRESENTATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; MODELS, THEORETICAL; NEOPLASMS;

EID: 35448974557     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.03.038     Document Type: Article

References (22)

1. Steiman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9 (1991) 271-296
2. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90 (1997) 3245-3287
3. Thery C., and Amigorena S. The cell biology of antigen presentation in dendritic cells. Curr Opin Immunol 13 (2001) 45-51
4. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., Parish I.A., et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199 (2004) 9-26
5. Belz G.T., Carbone F.R., and Heath W.R. Cross-presentation of antigens by dendritic cells. Crit Rev Immunol 22 5-6 (2002) 439-448
6. Hummell D.S. The role of T-cell receptors in health and disease. Compr Ther 20 11 (1994) 616-622
7. Elbe A., and Stingl G. Dendritic cells as stimulator cells of MHC class I-restricted immune responses. Adv Exp Med Biol 378 (1995) 341-345
8. Bernard A., Lamy And L., and Alberti I. The two-signal model of T-cell activation after 30 years. Transplantation 73 Suppl. 1 (2002) S31-S35
9. Wingren A.G., Parra E., Varga M., Kalland T., Sjogren H.O., Hedlund G., et al. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol 15 3-4 (1995) 235-253
10. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 14 (1996) 233-258
11. Kosmaczewska A., Ciszak L., Bocko D., and Frydecka I. Expression and functional significance of CTLA-4, a negative regulator of T cell activation. Arch Immunol Ther Exp (Warsz) 49 1 (2001) 39-46
12. Lutz M.B., and Schuler G. Immature, semi-immature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trend Immunol 23 (2002) 445-449
13. Kanai T., Totsuka T., Uraushihara K., Makita S., Nakamura T., Koganei K., et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol 171 8 (2003) 4156-4163
14. Safley S.A., Kapp L.M., Tucker-Burden C., Hering B., Kapp J.A., and Weber C.J. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways. Transplantation 79 4 (2005) 409-418
15. Tolcher A.W. Regulators of apoptosis as anticancer targets. Hematol Oncol Clin North Am 16 5 (2002) 1255-1267
16. Breidenbach M., Rein D.T., Schondorf T., Schmidt T., Konig E., Valter M., et al. Hematological side-effect profiles of individualized chemotherapy regimen for recurrent ovarian cancer. Anticancer Drugs 14 5 (2003) 341-346
17. Sloan J.A., Goldberg R.M., Sargent D.J., Vargas-Chanes D., Nair S., Cha S.S., et al. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol 20 6 (2002) 1491-1498
18. Lemarie A., Morzadec C., Bourdonnay E., Fardel O., and Vernhet L. Human macrophages constitute targets for immunotoxic inorganic arsenic. J Immunol 177 5 (2006) 3019-3027
19. Wang D., Kleist C., Ehser S., Opelz G., and Terness P. Ex vivo perfusion with mitomycin C containing solution prolongs heart graft survival in rats. Transplantation 82 11 (2006) 1537-1540
20. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
21. Suciu-Foca N., Manavalan J.S., and Cortesini R. Generation and function of antigen-specific suppressor and regulatory T cells. Transpl Immunol 11 3-4 (2003) 235-244
22. Devey L.R., and Wigmore S.J. Is death the price of tolerance?. Transplantation 82 11 (2006) 1411-1412